Explore News By Topic
11/17/2023
Pfizer and Astellas’ XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy* in nonmetastatic castration-sensitive prostate cancer TOKYO and NEW YORK, November 16, 2023 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Pfizer Inc. (NYSE: PFE) today... Read More
10/25/2023
The Prostate Cancer Foundation and Bayer Announce First Ever Bayer-PCF Darolutamide Challenge Awards
LOS ANGELES, Calif., October 25, 2023 – The Prostate Cancer Foundation (PCF) and Bayer today announced two 2023 Bayer-PCF Darolutamide Challenge Awards totaling $2 million to support clinical investigations on darolutamide in prostate cancer. In 2019, the U.S. Food and Drug Administration approved Bayer’s Nubeqa® (darolutamide), an androgen receptor inhibitor... Read More
10/24/2023
The Prostate Cancer Foundation Announces The 2023 Young Investigator Awards Totaling More Than $6 Million for Prostate Cancer Research
LOS ANGELES, Calif., October 24, 2023 – The Prostate Cancer Foundation (PCF) today announced the Class of 2023 Young Investigator Award recipients totaling $6.1 million in funding for innovative prostate cancer research. PCF Young Investigator Awards are intended to identify a cohort of future research leaders who will keep the... Read More
10/04/2023
Washington Commanders announce month-long programming promoting early detection and celebrating survivors and those currently undergoing treatment as part of NFL’s ‘Crucial Catch’ campaign
LANDOVER, Md., October 4, 2023 – Throughout the month of October, the Washington Commanders will host events dedicated to health equity and promoting early detection best practices as part of the NFL's Annual Crucial Catch initiative. To headline the month, the team will host its Crucial Catch-themed game under the... Read More
08/31/2023
The Prostate Cancer Foundation Challenges America To Get Healthy This September
LOS ANGELES, Calif., August 31, 2023 – September is Prostate Cancer Awareness Month and the Prostate Cancer Foundation (PCF) is challenging all Americans to Get Healthy with PCF by joining two Prostate Cancer Awareness Challenges: 108 Miles in September Run/Walk Challenge and 30 Foods in 30 Days Healthy Eating Challenge.... Read More
06/16/2023
MLB commemorates Father’s Day in partnership with Prostate Cancer Foundation
For its 27th season, MLB and PCF has teamed up to host the Home Run Challenge. Each home run hit in all games beginning May 20 and leading up to Father’s Day (June 18) have raised money to fight prostate cancer. Fans can still visit pcf.org/homerunchallenge to pledge a donation for... Read More
06/08/2023
ZERO Prostate Cancer Taps Breast Cancer Leader and Survivor as Next President and CEO
Washington, D.C., June 8, 2023 - After a nationwide executive search, ZERO Prostate Cancer proudly announces Courtney Bugler, CFRE, as its new President and CEO, effective August 7. Bugler, a trailblazing nonprofit leader with extensive executive experience in national health nonprofits, fundraising, and advocacy, will succeed the current President and... Read More
05/31/2023
Major League Baseball and Prostate Cancer Foundation Partner on 27th Annual Home Run Challenge and Tour
LOS ANGELES, Calif., May 31, 2023 – The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are teaming up for the 27th Annual Home Run Challenge and Tour now through Father’s Day, June 18, to raise funds and awareness in the fight against prostate cancer through America’s National Pastime.... Read More
05/24/2023
Prostate Cancer Foundation-Funded Study Sheds Light on Improving Access to Precision Oncology Care for U.S. Veterans with Prostate Cancer
LOS ANGELES, Calif., May 24, 2023 – A team of Prostate Cancer Foundation (PCF)-funded researchers found that U.S. Veterans with cancer who receive in-person genetics counseling versus a telehealth consult are significantly more likely to complete full germline genetic testing, findings which may help address disparities in patient access to... Read More
04/05/2023
Prostate Cancer Foundation-Funded Research Identifies Promising Precision Immunotherapy Approach for Advanced Prostate Cancer
LOS ANGELES, Calif., April 5, 2023 – Although immunotherapies can successfully treat many types of cancer, they have shown limited effectiveness in advanced prostate cancer that has become resistant to treatment, known as metastatic castration-resistant prostate cancer (mCRPC). New findings from a Prostate Cancer Foundation (PCF)-funded investigator reveal the mechanisms... Read More